Bariatric & Metabolic Surgery

Obesity Surgery in Lucknow

Medically reviewed by Dr A K Bansal · M.Ch Surgical Gastroenterology (SGPGI AIR 1) · UP MC Reg 110052

Dr A K Bansal provides comprehensive bariatric (obesity) surgery at Dr Bansal Gastro & Liver Centre, Gomti Nagar Extension and Myra City Hospital, Lucknow. The service covers laparoscopic sleeve gastrectomy, Roux-en-Y gastric bypass, mini-gastric bypass (OAGB) and structured pre- and post-operative multidisciplinary care. Practice follows the IFSO (International Federation for the Surgery of Obesity), IFSO-APC, ASMBS (American Society for Metabolic and Bariatric Surgery) and OSSI (Obesity and Metabolic Surgery Society of India) guidelines.

Overview of Obesity Surgery

Obesity surgery — also called bariatric surgery or metabolic surgery — is a group of laparoscopic operations that produce durable weight loss and metabolic improvement in patients with severe obesity. The procedures work through three mechanisms: a degree of restriction in food volume, alteration of gut hormone signalling (most notably ghrelin, GLP-1 and PYY), and — in bypass operations — a small element of malabsorption.

Internationally, bariatric surgery is recognised as the most effective long-term treatment for severe obesity by every major guideline body — the International Federation for the Surgery of Obesity (IFSO), the American Society for Metabolic and Bariatric Surgery (ASMBS), the Obesity and Metabolic Surgery Society of India (OSSI), the American Diabetes Association (ADA) and the NIH. Comparative trials and long-term registry data consistently show greater and more durable weight loss, better resolution of obesity-related comorbidity, and improved survival compared with non-surgical management of severe obesity.

Dr A K Bansal offers the full spectrum of standard bariatric and metabolic procedures, with technique chosen on the basis of patient BMI, comorbidities (especially type 2 diabetes and severe reflux), eating pattern and personal preference, after multidisciplinary evaluation.

Why Surgery and Not Just Diet?

Lifestyle and pharmacological treatment remain the foundation of any obesity management plan. However, beyond a certain severity of obesity, hormonal and metabolic adaptations make sustained weight loss extremely difficult with diet alone. Once the body has been in a state of severe obesity for years, the appetite-regulating system defends a higher set-point — patients who lose weight through diet typically regain most of it within 2–5 years.

Bariatric surgery alters this set-point by changing gut hormone signalling and gastric capacity simultaneously. The result is sustained weight loss, durable improvement in many comorbidities (type 2 diabetes, hypertension, OSA, fatty liver, dyslipidaemia, joint disease), and improvements in quality of life. Surgery is not a cosmetic intervention — it is a treatment for a chronic metabolic disease.

Who Is Eligible for Obesity Surgery?

Indian eligibility criteria reflect the higher health risk of obesity at lower BMI thresholds in Asian populations. Per the IFSO Asia-Pacific Chapter and OSSI guidance, current Indian thresholds are:

  • BMI ≥ 37.5 kg/m² without comorbidity
  • BMI ≥ 32.5 kg/m² with at least one significant comorbidity — type 2 diabetes, hypertension, obstructive sleep apnoea, severe NAFLD/NASH, dyslipidaemia, severe joint disease, PCOS with infertility
  • BMI ≥ 27.5 kg/m² with poorly controlled type 2 diabetes — metabolic surgery indication, per the 2nd Diabetes Surgery Summit recommendations

Additional eligibility considerations include age (typically 18–65, with selected exceptions), failure of supervised non-surgical weight management, absence of untreated severe psychiatric illness or active substance misuse, and willingness to commit to lifelong follow-up.

Types of Obesity Surgery

  • Laparoscopic Sleeve Gastrectomy (LSG): the most commonly performed bariatric procedure worldwide. Approximately 75–80% of the stomach is removed along the greater curvature, leaving a vertical tubular stomach. Restriction + reduced ghrelin secretion drive weight loss and metabolic improvement.
  • Laparoscopic Roux-en-Y Gastric Bypass (RYGB): a small (15–30 mL) gastric pouch is created and connected directly to the mid-jejunum via a Roux limb. Strong durable weight loss and the most evidence for diabetes remission.
  • One-Anastomosis (Mini) Gastric Bypass (OAGB-MGB): a longer narrow gastric pouch connected to a 150–200 cm bypassed limb of jejunum via a single anastomosis. Technically simpler than RYGB with comparable short-term outcomes; long-term data continues to accumulate.
  • SADI-S (Single-Anastomosis Duodeno-Ileal Bypass with Sleeve): a newer combined sleeve and duodeno-ileal bypass, used in selected patients with very high BMI or revisional cases.
  • Intra-gastric balloon: a temporary, endoscopically placed balloon that provides 5–10% body weight loss over 6–12 months. Non-surgical and reversible. Used in selected patients as a bridge or for those who do not meet surgical thresholds.

Choosing the Right Procedure

Procedure choice is personalised. Common considerations include:

  • Severe GERD / large hiatal hernia — gastric bypass (RYGB) is preferred over sleeve, which can worsen reflux
  • Type 2 diabetes — bypass procedures (RYGB, OAGB) have somewhat stronger metabolic effects than sleeve
  • Very high BMI (≥50) — bypass procedures or SADI-S may achieve better long-term weight loss
  • Patient preference for a simpler, lower-risk operation — sleeve gastrectomy is often the first choice
  • Anaemia, IBD, prior abdominal surgery, malabsorption concerns — affect bypass eligibility

The decision is made together with the patient after multidisciplinary review.

Pre-operative Work-up

Modern bariatric care requires a thorough multidisciplinary work-up:

  • Detailed history, including weight history, dietary pattern, comorbidities, mental health, prior weight-loss attempts
  • Examination, BMI, body composition
  • Routine blood investigations including HbA1c, lipid profile, liver function, thyroid function, vitamin B12, vitamin D, iron studies, electrolytes
  • Upper GI endoscopy to assess for hiatal hernia, GERD, H. pylori and ulcer disease
  • Ultrasound (gallstone screening) and abdominal evaluation as indicated
  • Cardiac evaluation, ECG, echocardiogram as indicated by age, BMI and comorbidity
  • Pulmonary evaluation, polysomnography if OSA suspected
  • Psychological/behavioural evaluation
  • Dietitian consultation
  • Anaesthetic review

Pre-operative weight loss (typically 5–10% of body weight over 2–4 weeks via a low-calorie/very-low-calorie diet) is encouraged to reduce liver size, decrease abdominal fat, and ease surgical exposure.

During & After Surgery

All standard bariatric operations are performed laparoscopically under general anaesthesia. Typical hospital stay is 2–3 nights for sleeve gastrectomy and 3–4 nights for gastric bypass. Drains and urinary catheters are removed early. Patients are mobilised on the same day and start clear liquids within 24 hours.

Dietary progression follows a staged plan over 4–6 weeks: clear liquids → full liquids → puréed foods → soft foods → regular textures, under dietitian supervision. Lifelong vitamin and mineral supplementation begins from day 1.

Expected Weight Loss

Typical results reported in major bariatric registries (IFSO, ASMBS BSAQIP):

  • Sleeve gastrectomy: 60–70% excess weight loss at 1–2 years; 50–60% at 5 years
  • Gastric bypass (RYGB): 70–80% excess weight loss at 1–2 years; 60–70% at 5 years
  • OAGB-MGB: comparable to RYGB in short-term outcomes

Individual results vary substantially with adherence to diet, physical activity, follow-up and behavioural factors. A degree of weight regain after the second year is common and is addressed through structured follow-up.

Comorbidity Outcomes

Beyond weight loss, bariatric and metabolic surgery produces meaningful improvement in many obesity-related conditions:

  • Type 2 diabetes: remission or substantial improvement in a large proportion of patients, particularly those with shorter diabetes duration
  • Hypertension: improvement or resolution in many patients
  • Obstructive sleep apnoea: improvement in CPAP requirements in most
  • Fatty liver (NAFLD/NASH): substantial improvement in liver steatosis, inflammation and fibrosis
  • Dyslipidaemia: improved lipid profile, particularly after bypass procedures
  • PCOS, infertility: often improves with weight loss
  • Joint pain and mobility: improves with weight loss
  • Quality of life: improves substantially in most patients

Long-term Follow-up

Modern bariatric care is structured for lifelong follow-up — this is integral, not optional, to long-term success:

  • Reviews at 1, 3, 6, 12 months and then annually
  • Blood tests for nutritional status — iron, vitamin B12, vitamin D, calcium, folate, protein
  • Bone health monitoring (DEXA where indicated)
  • Dietary review with the bariatric dietitian
  • Lifelong multivitamin, calcium, vitamin D and (after bypass) vitamin B12 supplementation
  • Behavioural and psychological support as needed

Risks & Complications

  • Mortality: 30-day mortality under 0.3% in experienced laparoscopic bariatric centres
  • Staple-line bleed — typically self-limiting; rarely needs intervention
  • Staple-line leak (sleeve) / anastomotic leak (bypass) — under 1–2%; serious but usually manageable when detected early
  • Deep vein thrombosis / pulmonary embolism — risk mitigated with chemical and mechanical prophylaxis
  • Internal hernia — specific to gastric bypass; managed by closure of all mesenteric defects intra-operatively
  • Reflux (post-sleeve) — addressed by procedure selection in patients with significant pre-operative reflux
  • Marginal ulcer (post-bypass) — risk reduced by smoking cessation, NSAID avoidance, PPI prophylaxis
  • Dumping syndrome (post-bypass) — managed by dietary modification
  • Long-term nutritional deficiencies — mitigated by lifelong supplementation and follow-up
  • Weight regain — possible after 2–5 years; addressed through behavioural and dietary support

Why Choose Dr A K Bansal for Obesity Surgery

Dr A K Bansal completed his M.Ch Surgical Gastroenterology at SGPGI Lucknow with All India Rank 1. He is Ex Senior Consultant in the Department of Gastrosciences at Medanta Hospital and currently heads the Department of GI Surgery at Myra City Hospital. With 15+ years of surgical experience and 5000+ procedures, his bariatric practice covers the full range of guideline-endorsed procedures.

  • Full range of bariatric and metabolic procedures — sleeve gastrectomy, gastric bypass, OAGB-MGB
  • Multidisciplinary pre-operative evaluation
  • Structured pre- and post-operative dietary support
  • Lifelong follow-up pathway with nutritional monitoring
  • Care aligned with IFSO, ASMBS, OSSI and IFSO-APC guidelines

Book a Bariatric Consultation

Bring recent blood tests, prior endoscopy or imaging, and a list of all medications.

Book Appointment

Frequently Asked Questions

What is obesity surgery?+

A group of laparoscopic operations that produce durable weight loss and metabolic improvement in severe obesity by restriction, gut hormone change and (in bypass) a degree of malabsorption.

Who is eligible for obesity surgery in India?+

Asian-Indian thresholds (IFSO-APC/OSSI): BMI ≥37.5 without comorbidity; BMI ≥32.5 with significant comorbidity; BMI ≥27.5 with poorly controlled type 2 diabetes.

What are the main types?+

Laparoscopic sleeve gastrectomy, Roux-en-Y gastric bypass, mini-gastric bypass (OAGB), SADI-S, and intragastric balloon (non-surgical). Choice is individualised.

How much weight will I lose?+

Typically 60–80% excess weight loss at 1–2 years with sleeve or bypass. Individual results vary with adherence and follow-up.

Can bariatric surgery reverse type 2 diabetes?+

Bariatric surgery produces sustained remission or substantial improvement of type 2 diabetes in many patients — particularly with shorter diabetes duration. Endorsed by the Diabetes Surgery Summit and ADA.

What are the risks?+

30-day mortality under 0.3% in experienced centres. Major complications 3–5%. Recognised risks include bleed, leak, DVT/PE, internal hernia, reflux, marginal ulcer and long-term nutritional deficiencies.

Do I need lifelong follow-up?+

Yes. Structured follow-up at 1, 3, 6, 12 months then annually, with blood tests for nutritional status and lifelong multivitamin supplementation. Follow-up is integral to long-term success.

Call WhatsApp Book